Takeda Pharmaceutical Co Ltd

26.770-0.2400-0.89%Vol 5091Y Perf -23.62%
Nov 29th, 2021 12:05
BID0.0000 ASK0.0000
Open26.554 Previous Close27.010
Pre-Market- After-Market-
 - -  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★+     57.80
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
★★★★+     56.54
Price Range Ratio 52W %
1.62 
Earnings Rating
Market Cap- 
Earnings Date
-
Alpha-0.02 Standard Deviation0.08
Beta0.95 

Today's Price Range

26.55426.770

52W Range

26.55439.900

5 Year PE Ratio Range

14.000152.10

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-3.37%
1 Month
-3.88%
3 Months
-18.88%
6 Months
-21.93%
1 Year
-23.62%
3 Years
-26.10%
5 Years
-35.69%
10 Years
0.00%

TickerPriceChg.Chg.%
TKPHF26.770-0.2400-0.89
AAPL160.243.43002.19
GOOG2 922.2866.16002.32
MSFT336.636.95002.11
XOM61.590.34000.56
WFC49.160.73001.51
JNJ159.750.55000.35
FB338.034.91001.47
GE98.400.56000.57
JPM161.23-0.7000-0.43
Financial StrengthValueIndustryS&P 500US Markets
0.80
1.30
0.43
0.79
5.20
Leverage Ratio 2.50
ProfitabilityValueIndustryS&P 500US Markets
69.90
19.10
35.70
8.40
14.03
RevenueValueIndustryS&P 500US Markets
29.59B
18.81
-
-
DividendsValueIndustryS&P 500US Markets
5.06
1.71
25.99
3.72
Payout ratio32.00
Earnings HistoryEstimateReportedSurprise %
Q03 2019-1.48-
Q02 2019-1.08-
Q01 2019-1.37-
Q03 2018-0.85-
Q02 2018-0.70-
Q01 2018-0.93-
Q01 2017-0.66-
Q04 2016-0.15-
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume509
Shares Outstanding0
Shares Float1.32B
Trades Count8
Dollar Volume13.65K
Avg. Volume35.84K
Avg. Weekly Volume3.40K
Avg. Monthly Volume7.92K
Avg. Quarterly Volume28.47K
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating-
0.00
-
0.00
-
0.00

Takeda Pharmaceutical Co Ltd

Takeda Pharmaceutical Co Ltd ("Takeda") is Japan's largest pharmaceutical company, with revenue of JPY 2.1 trillion in 2018. In January 2019, it closed its acquisition of Shire Plc ("Shire"), a diversified, Ireland-based specialty drug firm with $15 billion revenue in 2017, mostly derived from the U.S.. In future, management intends to focus future R&D and sales efforts on five areas: oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which comprise approximately 75% of revenue.

CEO: Christophe Weber

Telephone: +81 332782306

Address: 1-1, Nihonbashi-Honcho 2-Chome, Tokyo 103-8668, , JPN

Number of employees: 49 578

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

0%100%

Bearish Bullish

41%59%

Bearish Bullish

55%45%

News